Skip to product information
1 of 1

Symptomatic Dermographism Activity Score (SDAS)

Symptomatic Dermographism Activity Score (SDAS)

Regular price €0,00 EUR
Regular price Sale price €0,00 EUR
Sale Sold out
+ 19% tax where applicable.
View full details

Description

The SDAS is a disease-specific questionnaire that assesses disease activity in patients with symptomatic dermographism. It consists of a daily eleven-item questionnaire that is quick and easy to use.

The SDAS was developed at the Charité by a team headed by Dr. Melba Munoz, Dr. Karsten Weller and Prof. Marcus Maurer. The questions included in the SDAS were generated together with the help of patients. Impact factor analyses as well an expert review for face validity, redundancy content and the development of a scoring system were considered for the generation of SDAS. The SDAS is also suitable for patient care as well as clinical research studies.

Quick Facts SDAS:
Number of items: 11
Suited for: All adults (≥18 years old) patients with symptomatic dermographism
Assessment: prospectively, every day
Scoring: Easy sum scoring
Copyright: Moxie GmbH (www.moxie-gmbh.de)
Terms of use: Free for routine clinical use and non commercial research, small fee for use in clinical trials/commercial research

Reference:
coming soon

Commercial or non-commercial

If you are interested or on request, we will be happy to send you our PROMs (Patient Reported Outcomes Measures) on the various topics by e-mail. 

Please understand that we have to charge a fee of 15 Euro per PRO when using our PROMs for commercial purposes. Commercial use include, for example, use in industry-sponsored studies, market research and similar purposes.

By non-commercial use we mean e.g. use for consultation hours in hospitals and private practices, use within scientific studies without sponsoring. The prerequisite is that no commercial interest is pursued.

Frequently Asked Questions

Why are there PRO (Patient Reported Outcomes) products that cost nothing and others that cost 15 Euros?

If you plan to use PRO (Patient Reported Outcomes) products (e.g. AAS, AE-QoL, UCT) commercially, there is a small fee per patient (15 €). This applies, for example, to industry-sponsored trials and clinical studies or market research.
You can order free versions, if you plan to use them for non commercial purposes, e.g. for patient management or for academia-driven non commercial
research projects. When you order PRO (Patient Reported Outcomes) products, these instruments are sent per e-mail.

I would like to use PRO (Patient Reported Outcomes) products commercially. Do I have to buy one version each for every time I plan to use it, even in the same patient?

No. Each PRO (Patient Reported Outcomes) products you purchase can be used multiple time by the same patient.

What do I do if PRO (Patient Reported Outcomes) products are not available for my country or in the language I need?

The version you are looking for is probably already under development. Feel free to get in touch with us by e-mail to check when it will be available.